Patients who have a higher risk of developing breast and ovarian cancer can benefit from care that delivers consistent messaging and a unified approach.
Cancer-Risk Psychology: Helping Patients Live with Genetic Test Results
A psychologist specializing in hereditary cancer risk shares insights for how to help ensure patients’ cancer risk knowledge proves to be empowering, not burdensome.
Update on the Role of PARP Inhibitors in Epithelial Ovarian Cancer
The data are promising regarding PARP inhibitors, especially in recurrent ovarian cancer. Gynecologic oncologists are awaiting results of current trials in patients with newly diagnosed ovarian cancer as part of primary therapy.